F. Barre-sinoussi, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, vol.220, pp.868-871, 1983.

R. J. Shattock and J. P. Moore, Inhibiting sexual transmission of HIV-1 infection, Nature reviews. Microbiology, vol.1, pp.25-34, 2003.
DOI : 10.1038/nrmicro729

A. T. Haase, Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annual review of medicine 62, pp.127-139, 2011.
DOI : 10.1146/annurev-med-080709-124959

M. Bomsel and A. Alfsen, Entry of viruses through the epithelial barrier: pathogenic trickery, Nature reviews. Molecular cell biology, vol.4, pp.57-68, 2003.
DOI : 10.1038/nrm1005

A. Burgener, I. Mcgowan, and N. R. Klatt, HIV and mucosal barrier interactions: consequences for transmission and pathogenesis, Current opinion in immunology, vol.36, pp.22-30, 2015.
DOI : 10.1016/j.coi.2015.06.004

C. Cicala, J. Arthos, and A. S. Fauci, HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV, Journal of translational medicine, vol.9, issue.1, 2011.

B. J. Connell and H. Lortat-jacob, Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition, Frontiers in immunology, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00385
URL : https://hal.archives-ouvertes.fr/hal-00924124

K. K. Arien, V. Jespers, and G. Vanham, HIV sexual transmission and microbicides, Reviews in medical virology, vol.21, pp.110-133, 2011.

, Scientific RepoRts |, vol.6

F. Hladik and G. F. Doncel, Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities, Antiviral research, vol.88, 2010.
DOI : 10.1016/j.antiviral.2010.09.011
URL : http://europepmc.org/articles/pmc3032991?pdf=render

Q. A. Karim and C. Baxter, Microbicides for the prevention of sexually transmitted HIV infection. Expert review of anti-infective therapy 11, pp.13-23, 2013.

P. J. Klasse, R. Shattock, and J. P. Moore, Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annual review of medicine 59, pp.455-471, 2008.
DOI : 10.1146/annurev.med.59.061206.112737

V. Pirrone, B. Wigdahl, and F. C. Krebs, The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1, Antiviral research, vol.90, pp.168-182, 2011.

J. W. Romano, M. Robbiani, G. F. Doncel, and T. Moench, Non-specific microbicide product development: then and now, Current HIV research, vol.10, pp.9-18, 2012.

S. Tan, Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection, PloS one, vol.8, p.59777, 2013.

L. Van-damme, Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission, The New England journal of medicine, vol.359, pp.463-472, 2008.

C. Moog, Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques, Mucosal immunology, vol.7, pp.46-56, 2014.

A. Pegu, Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor, Science translational medicine, vol.6, pp.243-288, 2014.

J. M. Baeten, Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women, The New England journal of medicine, 2016.

D. C. Sokal, Safety of tenofovir gel, a vaginal microbicide, South African women: results of the CAPRISA 004 Trial, vol.18, pp.301-310, 2013.

R. K. Malcolm, Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques, The Journal of antimicrobial chemotherapy, vol.68, pp.678-683, 2013.

B. A. Chen, Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A DoubleBlind Randomized Trial, Journal of acquired immune deficiency syndromes, vol.70, pp.242-249, 1999.

F. Baleux, A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry, Nat Chem Biol, vol.5, pp.743-748, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00415325

B. J. Connell, A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti-HIV-1 activity independently of coreceptor usage, Chemistry & biology, vol.19, pp.131-139, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00664771

E. Crublet, J. P. Andrieu, R. R. Vives, and H. Lortat-jacob, The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site, J Biol Chem, vol.283, pp.15193-15200, 2008.

R. R. Vives, A. Imberty, Q. J. Sattentau, and H. Lortat-jacob, Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site, J Biol Chem, vol.280, pp.21353-21357, 2005.

M. Farzan, Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry, Cell, vol.96, pp.667-676, 1999.

B. F. Keele, Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proceedings of the National Academy of Sciences of the United States of America 105, pp.7552-7557, 2008.

P. A. Marx, Progesterone implants enhance SIV vaginal transmission and early virus load, Nature medicine, vol.2, pp.1084-1089, 1996.

A. Aarnink, Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque, Immunogenetics, vol.63, pp.267-274, 2011.

N. Dereuddre-bosquet, MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques, PLoS pathogens, vol.8, p.1003071, 2012.

M. M. Lederman, Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5, Science, vol.306, pp.485-487, 2004.

C. C. Tsai, Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models, AIDS research and human retroviruses, vol.20, pp.11-18, 2004.

R. S. Veazey, Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor, The Journal of infectious diseases, vol.202, pp.739-744, 2010.

R. S. Veazey, Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion, Nature, vol.438, pp.99-102, 2005.

K. Grupping, MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency, Retrovirology, vol.9, p.36, 2012.

L. Morellato-castillo, Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein, Journal of medicinal chemistry, vol.56, pp.5033-5047, 2013.

M. Caskey, Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117, Nature, vol.522, pp.487-491, 2015.

K. K. Arien, Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission, The Journal of antimicrobial chemotherapy, vol.68, pp.2038-2047, 2013.

P. Selhorst, Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides, Antimicrobial agents and chemotherapy, vol.55, pp.1403-1413, 2011.

S. M. Schader, HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug, Antimicrobial agents and chemotherapy, vol.56, pp.4257-4267, 2012.

T. T. Murooka, HIV-infected T cells are migratory vehicles for viral dissemination, Nature, vol.490, pp.283-287, 2012.
DOI : 10.1038/nature11398
URL : http://europepmc.org/articles/pmc3470742?pdf=render

Q. J. Sattentau, The direct passage of animal viruses between cells, Current opinion in virology, vol.1, pp.396-402, 2011.

M. Sourisseau, N. Sol-foulon, F. Porrot, F. Blanchet, and O. Schwartz, Inefficient human immunodeficiency virus replication in mobile lymphocytes, Journal of virology, vol.81, pp.1000-1012, 2007.
DOI : 10.1128/jvi.01629-06
URL : https://hal.archives-ouvertes.fr/pasteur-00292736

M. Malbec, Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission, The Journal of experimental medicine, vol.210, pp.2813-2821, 2013.
DOI : 10.1084/jem.20131244
URL : https://hal.archives-ouvertes.fr/pasteur-01108608

C. C. Huang, Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptorbinding site on gp120, Proceedings of the National Academy of Sciences of the United States of America, vol.101, pp.2706-2711, 2004.

G. P. Andrews, Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery, Biomacromolecules, vol.10, pp.2427-2435, 2009.

, Scientific RepoRts |, vol.6

R. S. Veazey, Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge, The Journal of infectious diseases, vol.199, pp.1525-1527, 2009.
DOI : 10.1086/598685
URL : https://academic.oup.com/jid/article-pdf/199/10/1525/18056564/199-10-1525.pdf

R. Valdez and K. P. , Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains, Virology, vol.475, pp.187-203, 2015.

B. Amadi, Reduced production of sulfated glycosaminoglycans occurs in Zambian children with kwashiorkor but not marasmus, The American journal of clinical nutrition, vol.89, pp.592-600, 2009.

A. Ceballos, Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells, The Journal of experimental medicine, vol.206, pp.2717-2733, 2009.
DOI : 10.1083/jcb1873oia5

B. M. Dale, R. A. Alvarez, and B. K. Chen, Mechanisms of enhanced HIV spread through T-cell virological synapses, Immunological reviews, vol.251, pp.113-124, 2013.
DOI : 10.1111/imr.12022

I. A. Abela, Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies, PLoS pathogens, vol.8, p.1002634, 2012.
DOI : 10.1371/journal.ppat.1002634
URL : https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002634&type=printable

A. Sigal, Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy, Nature, vol.477, pp.95-98, 2011.

D. H. Barouch, Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys, Nature, vol.503, pp.224-228, 2013.

M. Shingai, Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques, The Journal of experimental medicine, vol.211, pp.2061-2074, 2014.

J. A. Schwartz, An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques, Clinical and vaccine immunology : CVI, vol.23, pp.618-627, 2016.

J. M. Harouse, Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3), Journal of virology, vol.75, 1990.

J. M. Harouse, A. Gettie, R. C. Tan, J. Blanchard, and C. Cheng-mayer, Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs, Science, vol.284, pp.816-819, 1999.
DOI : 10.1126/science.284.5415.816

O. Bourry, Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir, AIDS, vol.23, pp.447-454, 2009.

A. Mannioui, Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques, Retrovirology, vol.6, 2009.

A. Lepelley, Innate sensing of HIV-infected cells, PLoS pathogens, vol.7, p.1001284, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00590930

T. Bruel, Elimination of HIV-1-infected cells by broadly neutralizing antibodies, Nature communications, vol.7, p.10844, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01372390